Prima. Image: Science Corporation
Prima is a thin photovoltaic sub-retinal implant that can restore vision for those with geographic atrophy.
US neural engineering company Science Corporation has received EU approval for its vision repairing medtech implant.
‘Prima’ is the world’s “first and only treatment” shown to restore functional central vision in patients with geographic atrophy (GA) caused by age-related macular degeneration (AMD) – a leading cause of irreversible blindness that affects more than 5m people globally.
With regulatory approval at hand, the small, thin photovoltaic sub-retinal implant can be commercially sold across 30 European countries.
